China NT Pharma Group Company Limited (HKG:1011)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7200
-0.0100 (-1.37%)
Apr 2, 2026, 11:44 AM HKT
Market Cap683.28M +394.3%
Revenue (ttm)26.88M -36.4%
Net Income-28.98M
EPS-0.94
Shares Out949.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume120,000
Average Volume163,343
Open0.7100
Previous Close0.7300
Day's Range0.7100 - 0.7200
52-Week Range0.2200 - 1.3500
Beta-2.29
RSI44.44
Earnings DateMar 31, 2026

About HKG:1011

China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China. It operates through Digital Services and Sales Agency Service segments. The company acts as agent for clients to sell medical and health-related products to external customers. It also provides marketing and promotion in relation to bone health knowledge. In addition, the company is involved in trading of prescription medicines... [Read more]

Sector Healthcare
Founded 1995
Employees 21
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1011
Full Company Profile

Financial Performance

In 2025, HKG:1011's revenue was 24.16 million, a decrease of -36.36% compared to the previous year's 37.96 million. Losses were -26.04 million, -51.19% less than in 2024.

Financial numbers in CNY Financial Statements